Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated how the pituitary-ovarian axis recovers from suppression caused by reduced luteinizing hormone-releasing hormone agonist infusion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase 1988
- Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque Monkey 1985
Cited by (4)
- Serum Concentration and Urinary Excretion of the Luteinizing Hormone-Releasing Hormone Agonist Buserelin in Patients with Endometriosis 1989
- Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH‐<i>β</i> and bloactive LH but maintains elevated levels of LH‐<i>α</i> 1991
- Tratamiento endocrinológico de la endometriosis 1997
- Limitations in the Use of Combined Gonadotropin Releasing Hormone Analog and Human Menopausal Gonadotropin for In Vitro Fertilization 1990
References (21)
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase via openalex
- Suppression of Follicular Maturation by Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Starting during the Late Luteal Phase in the Stumptailed Macaque Monkey via openalex
- W1978860276 via openalex
- W2014955036 via openalex
- W2015817028 via openalex
- W2019037346 via openalex
- W2019569711 via openalex
- W2020387186 via openalex
- W2035862679 via openalex
- W2062386461 via openalex
- W2124297003 via openalex
- W2165758902 via openalex
- W2408018161 via openalex
- W2413158907 via openalex
- W2416197490 via openalex
- W2477008945 via openalex
- W6642239427 via openalex
- W6655167465 via openalex
- W140454929 via openalex
- W6715543788 via openalex
- W276356054 via openalex
Cited by (4)
- Tratamiento endocrinológico de la endometriosis 1997
- Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH‐<i>β</i> and bloactive LH but maintains elevated levels of LH‐<i>α</i> 1991
- Limitations in the Use of Combined Gonadotropin Releasing Hormone Analog and Human Menopausal Gonadotropin for In Vitro Fertilization 1990
- Serum Concentration and Urinary Excretion of the Luteinizing Hormone-Releasing Hormone Agonist Buserelin in Patients with Endometriosis 1989
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:20.810540+00:00
License: CC0
· commercial use OK